$ANGO·8-K

ANGIODYNAMICS INC · Jan 14, 7:33 AM ET

Compare

ANGIODYNAMICS INC 8-K

Research Summary

AI-generated summary

Updated

AngioDynamics Inc. CEO Presents at J.P. Morgan Healthcare Conference

What Happened
AngioDynamics, Inc. (ANGO) filed a Form 8-K on January 14, 2026 disclosing that President and CEO James Clemmer presented at the J.P. Morgan 44th Annual Healthcare Conference. The company furnished the presentation slides as Exhibit 99.1 under Regulation FD.

Key Details

  • Presenter: James Clemmer, President and Chief Executive Officer of AngioDynamics.
  • Event/date: J.P. Morgan 44th Annual Healthcare Conference on January 14, 2026.
  • Disclosure: Presentation slides furnished as Exhibit 99.1 to the Form 8-K.
  • Regulatory note: Disclosure made pursuant to Regulation FD (to ensure public access to material information).

Why It Matters
Investor presentations at major conferences give management a public platform to discuss strategy, product updates and company outlook; furnishing the slides lets investors and analysts review the same materials presented at the conference. This 8-K does not include additional financial results or executive changes—it formally documents the presentation and compliance with public disclosure rules.

Loading document...